ArticleEye (London, England)2026
Demographic trends and geographic disparities in malignant neoplasm of eye and adnexa-related mortality in the United States, 1999-2023.
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMortality patterns for malignant neoplasms of the eye and adnexa remain under-described at the national scale.
methodsUsing CDC WONDER (1999-2023), we identified U.S. decedents aged ≥25 years with ICD-10 C69 as the underlying cause. Age-adjusted mortality rates (AAMR; per 100,000, 2000 U.S. standard) and trends were assessed with Joinpoint regression; analyses were stratified by sex, age, census region, urbanisation, place of death, and education.
resultsNational AAMR rose from 0.12 (95% CI: 0.10-0.14) in 1999 to 0.16 (0.14-0.17) in 2023 (peak 2021), yielding a significant monotonic increase. (Annual percent change, APC, +1.34%; 95% CI: 0.92-1.76; p < 0.001). Male AAMR exceeded female AAMR, but the relative rise was steeper in females (APC 1.80% vs. 1.16%). Regional disparities were pronounced (West highest, Northeast lowest), with a post-2016 acceleration in the South. Metropolitan areas showed a modest but significant increase; nonmetropolitan trends were volatile and not statistically significant. From 1999 to 2020, home and hospice deaths increased while hospital deaths were comparatively stable. Education-related differences narrowed slightly in 2021-2023 but remain uncertain. State-level estimates were sparse and unstable due to suppression.
conclusionsU.S. mortality from ocular and adnexal cancers increased modestly over 1999-2023 with persistent sex, regional, and urban-rural disparities. Findings support registry linkages and targeted prevention, referral, and palliative strategies, and offer a suppression-aware template for international surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.